1. Home
  2. PTLE vs TLPH Comparison

PTLE vs TLPH Comparison

Compare PTLE & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PTLE

PTL LTD Ordinary Shares

N/A

Current Price

$5.70

Market Cap

34.5M

Sector

Energy

ML Signal

N/A

Logo Talphera Inc.

TLPH

Talphera Inc.

HOLD

Current Price

$0.99

Market Cap

42.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLE
TLPH
Founded
2013
2005
Country
Singapore
United States
Employees
11
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.5M
42.3M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
PTLE
TLPH
Price
$5.70
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.1K
151.7K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.38
52 Week High
$16.17
$1.57

Technical Indicators

Market Signals
Indicator
PTLE
TLPH
Relative Strength Index (RSI) 52.72 73.38
Support Level $4.33 $1.01
Resistance Level $6.00 $1.44
Average True Range (ATR) 0.61 0.06
MACD 0.09 0.02
Stochastic Oscillator 76.71 93.24

Price Performance

Historical Comparison
PTLE
TLPH

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, serving the Asia Pacific market. The company's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers on time; and handling disputes, mainly concerning quality and quantity issues on marine fuel. The company derives its maximum revenue from Hong Kong.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: